Key Moments
Axel Montagne, PhD, on Solving Alzheimer’s and Dementia with Blood-Brain Barrier Repair
FoundMyFitnessKey Moments
Dementia may be a vascular disease; repairing blood-brain barriers shows promise for prevention and treatment.
Key Insights
Dementia, including Alzheimer's, has a significant vascular component, with blood-brain barrier dysfunction being an early indicator.
Exercise is crucial for brain health, maintaining the integrity of tiny blood vessels which are vital for neuron survival.
New MRI techniques and plasma biomarkers can detect blood-brain barrier leakiness years before cognitive decline appears.
Vascular dysfunction and amyloid plaques appear to be independent but interconnected pathways contributing to dementia.
Targeting blood vessel repair, including pericytes and endothelial cells, offers promising therapeutic strategies.
Lifestyle factors like omega-3 intake, managing hypertension, and avoiding pollution are important for vascular brain health.
THE VASCULAR ORIGINS OF DEMENTIA
Emerging research suggests that dementia, including Alzheimer's disease, has a significant vascular component. While amyloid plaques and tau tangles are well-known hallmarks, studies from decades ago already indicated widespread vascular problems in postmortem brains of Alzheimer's patients. In the last decade, this vascular phenotype has gained more attention, revealing that dysfunction and leakiness of brain blood vessels can precede and contribute to cognitive decline. This vascular component is a commonality across various forms of dementia, indicating a potential paradigm shift in understanding and treating these conditions.
EXERCISE AND THE VITAL ROLE OF CAPILLARIES
Regular, high-intensity exercise is paramount for maintaining brain health. The brain relies on a vast network of tiny capillaries, which constitute 90% of its vasculature. When not adequately exercised, these vessels can constrict, collapse, and disappear, leading to a loss of oxygen and nutrients for surrounding neurons. This vascular compromise directly impacts cognitive function and increases vulnerability to cognitive decline, especially in individuals with genetic predispositions. Therefore, exercise is presented not just as a general health recommendation but as a non-negotiable strategy for preserving brain function.
DETECTING BLOOD-BRAIN BARRIER DYSFUNCTION EARLY
Advances in neuroimaging, particularly detailed MRI techniques, allow for the detection of blood-brain barrier (BBB) leakiness. This leakiness can be observed in specific brain regions, such as the hippocampus, even in cognitively normal individuals as they age. Furthermore, plasma and cerebrospinal fluid biomarkers are being developed to quantify BBB integrity. These tools can predict future cognitive decline, identifying individuals at higher risk years in advance. Notably, the areas exhibiting BBB leakiness often do not overlap with the areas where amyloid plaques initially form, suggesting distinct pathological pathways.
THERAPEUTIC TARGETS FOR VASCULAR REPAIR
The focus is shifting towards repairing and protecting brain vasculature. Key cellular components like pericytes, which wrap around blood vessels, are crucial for BBB integrity. Their detachment and death, observed early in aging and certain diseases, lead to leakiness and reduced blood flow. Therapeutic strategies are being explored to target endothelial cells and pericytes, utilizing approaches like gene therapy and stem cell therapy. Protecting these cells and restoring their function offers hope for preventing neurodegeneration and preserving cognitive function.
INFLAMMATION, PERICYTES, AND THE AGING BRAIN
Crosstalk between endothelial cells and pericytes is vital for vascular health. As we age, endothelial cells can adopt a pro-inflammatory phenotype due to 'inflammaging,' leading to increased cell adhesion molecules that attract immune cells. This inflammation can cause pericytes to detach, physically allowing immune cells to enter the brain. This process, exacerbated by aging, disrupts BBB integrity and reduces blood flow. Inflammation is proposed as a leading trigger for pericyte loss and subsequent vascular issues, highlighting inflammation management as a potential therapeutic avenue.
LIFESTYLE FACTORS AND ENVIRONMENTAL IMPACT
Beyond therapeutic interventions, lifestyle choices significantly impact vascular brain health. Omega-3 fatty acids, particularly DHA and EPA, are increasingly recognized for their role in regulating BBB function through transporters like mfsd2a and their anti-inflammatory properties. Exercise remains a cornerstone of prevention. Additionally, environmental factors like air pollution have been shown to induce rapid BBB breakdown and vascular damage in animal models. Managing cardiovascular risk factors such as hypertension, diabetes, and hyperlipidemia is also critical, as chronic exposure can accelerate BBB dysfunction.
APOE4 GENETICS AND CYCLOPHILIN INHIBITION
Carrying the APOE4 gene variant is associated with a higher risk of Alzheimer's and is linked to increased BBB leakiness in specific brain regions. Research indicates that APOE4 influences pericyte function through interactions with receptors like NRP1, triggering a cascade involving cyclophilin A and MMP9. MMP9 can degrade tight junctions between endothelial cells and the basement membrane, compromising BBB integrity. Promisingly, blocking cyclophilin A with drugs like Alisporivir has shown partial restoration of vascular function, reduced neuronal damage, and cognitive improvement in animal models with APOE4, suggesting a potential targeted therapy.
SMALL VESSEL DISEASE: A DISTINCT BUT RELATED PATHOLOGY
Small vessel disease (SVD) is another major form of dementia, characterized by microbleeds, lacunes (small strokes), and white matter hyperintensities. While distinct from Alzheimer's, SVD also involves vascular dysfunction, including endothelial inflammation and pericyte issues. Hypertension is a known risk factor, but SVD can occur independently. Genetic forms of SVD, like CADASIL and CARASIL, directly involve pericytes and vascular smooth muscle cells, leading to early-onset dementia. Targeting these microvascular pathologies is crucial for preventing cognitive deterioration in SVD.
INTEGRATING TREATMENTS AND THE ROLE OF AMYLOID CLEARANCE
The complexity of dementia often involves multiple pathologies co-occurring. While therapies targeting amyloid plaques, like lecanemab, show some promise in clearing plaques, their impact on cognition remains controversial. This underscores the need for a multi-faceted approach. Future treatments may involve a 'cocktail' of therapies, combining vascular repair strategies that improve BBB function and amyloid clearance. Targeting vascular health early is likely more effective than late-stage amyloid removal, as a healthy vasculature is essential for clearing amyloid and other waste products from the brain.
THE GLYMPHATIC SYSTEM AND WASTE CLEARANCE
The glymphatic system, active during sleep, plays a vital role in clearing waste products, including amyloid-beta, from the brain via cerebrospinal fluid flow. Vascular disruption and BBB leakiness can significantly impair this clearance mechanism. While the precise mechanisms of the glymphatic system are still under intense investigation, it's clear that compromised vascular function will hinder the efficient removal of toxins, potentially leading to their accumulation and contributing to neurodegeneration. Therefore, maintaining BBB integrity is indirectly crucial for effective waste clearance.
MANAGING CARDIOVASCULAR RISK FACTORS
Controlling cardiovascular risk factors like hypertension, diabetes, and hyperlipidemia is essential for brain vascular health. Early-onset hypertension, in particular, may be more detrimental due to its prolonged duration and impact on blood vessel stiffness. While hypertension can trigger BBB leakage and pericyte loss, it's complex and often coexists with other conditions. Managing these factors through medication and lifestyle changes, such as exercise and potentially sauna use, can positively impact cognitive function and reduce dementia risk by preserving vascular integrity.
ALCOHOL CONSUMPTION AND VASCULAR IMPLICATIONS
The impact of alcohol on the blood-brain barrier is complex and subject to ongoing debate, with studies showing conflicting results regarding moderate consumption. However, chronic heavy alcohol consumption is consistently linked to increased BBB leakiness and vascular dysfunction, potentially due to elevated inflammatory markers in the blood. Some research suggests a gender-specific effect, with men showing more pronounced vascular impairment than women. While red wine contains beneficial compounds like resveratrol, the overall impact of alcohol on vascular brain health remains a nuanced area of study.
OBESITY, HOMOCYSTEINE, AND THE INFLAMMATORY CYCLE
Obesity is often associated with increased levels of pro-inflammatory markers, which can negatively affect BBB function. Intriguingly, some research suggests that BBB leakage might also trigger obesity by disrupting brain areas that control appetite and satiety. High homocysteine levels, another known risk factor for dementia and cardiovascular disease, are also associated with BBB dysfunction. Lowering homocysteine through B vitamin supplementation has shown promise in improving cognition and BBB integrity in some studies, highlighting the interconnectedness of bodily systems and brain health.
THE FUTURE OF DIAGNOSTICS AND PREVENTIVE MEASURES
The development of high-throughput technologies like electrochemiluminescence and Mesoscale Discovery (MSD) is accelerating the validation of new vascular biomarkers in blood and CSF. These advancements aim to provide accessible, early diagnostic tools for BBB dysfunction, similar to current glucose or amyloid testing. While these biomarkers are not yet widely available clinically, they represent a crucial step towards personalized diagnostics and preventive strategies. Early detection and intervention, potentially involving a combination of lifestyle changes and targeted therapies, offer the most promising path to combatting dementia.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Tools
●Organizations
●Concepts
●People Referenced
Preventing Dementia: Lifestyle & Intervention Summary
Practical takeaways from this episode
Do This
Avoid This
Common Questions
Regular aerobic exercise is crucial for maintaining tiny blood vessels in the brain. Lack of exercise can lead to these capillaries constricting, collapsing, and disappearing, resulting in neuron loss and increasing the propensity for cognitive decline, particularly when combined with genetic risks like APOE4.
Topics
Mentioned in this video
The main transporter of glucose at the blood-brain barrier, found to be reduced in Alzheimer's disease, impacting glucose flow to the brain.
A technique developed at USC to measure 'leakiness' of the blood-brain barrier, allowing visual detection of vascular problems in the brain.
A receptor on pericytes, a soluble form of which can be measured in plasma and CSF to indicate pericyte dysfunction in small vessel disease.
An imaging technique used to measure brain activity and glucose metabolism using tracers like FDG, often showing reduced signal in Alzheimer's.
An inflammatory protein involved in a cascade triggered by APOE4, leading to the expression of MMP9.
A non-type inhibitor of cyclophilin A, currently in clinical trials for Hepatitis C, shown to restore vascular function in APOE4 mice.
A platform utilizing electrochemiluminescence technology for high-throughput detection of new vascular biomarkers.
A blood coagulation protein that is toxic when deposited in the brain due to a leaky blood-brain barrier, causing neurotoxicity, oligodendrocyte death, and white matter disease.
A highly cited researcher in blood-brain barrier, who recently reviewed how blood-brain barrier leakage can trigger obesity.
A transporter specific to brain capillary blood vessels that regulates blood-brain barrier function and is a receptor for omega-3.
Mentioned as a world expert in cerebral small vessel disease at the University of Edinburgh.
Vitamins that can help lower high homocysteine levels, potentially improving cognition and blood-brain barrier function.
The institution where Dr. Axel Montagne is a professor and group leader at the Dementia Research Institute.
A major genetic risk factor for Alzheimer's disease, associated with increased vascular problems in the brain even in cognitively normal individuals.
Cells that wrap around blood vessels in the brain, crucial for maintaining blood-brain barrier integrity and preventing leakages; they detach and die with aging and disease.
An enzyme released due to cyclophilin A expression, which disrupts tight junctions and basement membranes, leading to blood-brain barrier breakdown.
A researcher at Gladstone University who developed an antibody to block the interaction between fibrinogen and microglia to prevent over-inflammation in the brain.
Where Dr. Montagne's team developed the MRI technique to detect blood-brain barrier leakage.
More from FoundMyFitness
View all 92 summaries
2 minWatch my episode with Dr. Charles Brenner
115 minHow To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging
92 minDr. Rhonda Patrick: Maximizing Healthspan with Exercise, Sauna, & Cold Exposure
131 minWhy Vigorous Exercise Is 4–10x More Effective Than Moderate (New Evidence)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free